Skip to main content
SpringerLink
Log in

Episkleritis und Skleritis (engl.: Scleritis; griechisch sklērós = spröde, hart)

  • Chapter
  • First Online:
Entzündliche Augenerkrankungen

  • 1418 Accesses

Zusammenfassung

ICD-10-Code H15.0 Skleritis

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur und weiterführende Literatur

  • Ahmed A, Foster CS (2019) Cyclophosphamide or rituximab treatment of scleritis and uveitis for patients with granulomatosis with polyangiitis. Ophthalmic Res 61:44–50

    CAS  PubMed  Google Scholar 

  • Akpek EK, Thorne JE, Qazi FA et al (2004) Evaluation of patients with scleritis for systemic disease. Ophthalmology 111(3):501–506

    PubMed  Google Scholar 

  • Bauer AM, Fiehn C, Becker MD (2005) Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis. Am J Ophthalmol 139(6):1086–1089

    CAS  PubMed  Google Scholar 

  • Bhat PV, Jakobiec FA, Kurbanyan K, Zhao T, Foster CS (2009) Chronic herpes simplex scleritis: characterization of 9 cases of an underrecognized clinical entity. Am J Ophthalmol 148(5):779–789

    PubMed  Google Scholar 

  • Botsios C, Sfriso P, Ostuni PA et al (2007) Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases. Rheumatology (Oxford) 46(6):1042–1043

    CAS  Google Scholar 

  • Chauhan S, Kamal A, Thompson RN et al (2009) Rituximab for treatment of scleritis associated with rheumatoid arthritis. Br J Ophthalmol 93(7):984–985

    CAS  PubMed  Google Scholar 

  • Das S, Mohamed A, Sangwan VS (2017) Clinical course and outcomes in patients with Mooren ulcer who had cataract surgery. J Cataract Refract Surg 43:1044–1049

    PubMed  Google Scholar 

  • Doctor P, Sultan A, Syed S, Christen W, Bhat P, Foster CS (2010) Infliximab for the treatment of refractory scleritis. Br J Ophthalmol 94(5):579–583

    PubMed  Google Scholar 

  • Foster CS, Forstot SL, Wilson LA (1984) Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology 91(10):1253–1263

    CAS  PubMed  Google Scholar 

  • Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, French Vascuilitis Study Group FVSG (2011) The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine 90(1):19–27

    PubMed  Google Scholar 

  • Hankins M, Margo CE (2019) Histopathological evaluation of scleritis. J Clin Pathol 72:386–390

    CAS  PubMed  Google Scholar 

  • Itty S, Pulido JS, Bakri SJ et al (2008) Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis. Trans Am Ophthalmol Soc 106:75–81

    PubMed  PubMed Central  Google Scholar 

  • Jabs DA, Rosenbaum JT, Foster CS, Louie JS, Jaffe GJ, Holland GN et al (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130(4):492–513

    CAS  PubMed  Google Scholar 

  • Jain V, Garg P, Sharma S (2009) Microbial scleritis-experience from a developing country. Eye 23(2):255–261

    CAS  PubMed  Google Scholar 

  • Kempen JH, Pistilli M, Begum H, Fitzgerald TD, Liesegang TL, Payal A, Zebardast N, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE (2019) Remission of non-infectious anterior scleritis: incidence and predictive factors. Am J Ophthalmol. 2019 Apr 3:S0002-9394(19)30134-5. doi: 10.1016

    Google Scholar 

  • Kim JS, Knickelbein JE, Nussenblatt RB, Sen HN (2016) Posterior scleritis. In: Medina C, Townsend J, Singh A (Hrsg) Manual of retinal diseases. Springer, Cham

    Google Scholar 

  • Lavric A, Gonzalez-Lopez JJ, Majumder PD, Bansal N, Biswas J, Pavesio C, Agrawal R (2016) Posterior scleritis: analysis of epidemiology, clinical factors, and risk of recurrence in a cohort of 114 patients. Ocul Immunol Inflamm 24:6–15

    PubMed  Google Scholar 

  • Lee WD, Devarajan K, Chua J et al (2019) Eye and Vis 6:4. https://doi.org/10.1186/s40662-019-0129-2

    Article  Google Scholar 

  • Levison AL, Lowder CY, Baynes KM et al (2016) Int Ophthalmol 36:499. (Springer). https://doi.org/10.1007/s10792-015-0153-8

    Article  PubMed  Google Scholar 

  • Majumder PD, Ali S, George A, Ganesh S, Biswas J (2019) Clinical profile of scleritis in children. Ocul Immunol Inflamm 27:535–539

    PubMed  Google Scholar 

  • de la Maza SM, Molina N, Gonzales-Gonzales LA et al (2012) Clinical Characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology 119:43–50

    Google Scholar 

  • McCluskey P, Wakefield D (1987) Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol 105(6):793–797

    CAS  PubMed  Google Scholar 

  • McCluskey PJ, Watson PG, Lightman S, Haybittle J, Restori M, Branley M (1999) Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology 106(12):2380–2386

    CAS  PubMed  Google Scholar 

  • McGavin DD, Williamson J, Forrester JV et al (1976) Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol 60(3):192–226

    CAS  PubMed  PubMed Central  Google Scholar 

  • Meyer PA, Watson PG, Franks W, Dubord P (1987) Pulsed immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease. Eye (Lond) 1:487–495

    Google Scholar 

  • Nida Sen H, Sangave AA, Goldstein DA, Suhler EB (2011) Denise Cunningham, Susan Vitale, Robert B. Nussenblatt a standardized grading system for scleritis. Ophthalmology 118(4):768–771

    PubMed  Google Scholar 

  • O’Donoghue E, Lightman S, Tuft S, Watson P (1992) Surgically induced necrotising sclerokeratitis (SINS) – precipitating factors and response to treatment. Br J Ophthalmol 76(1):17–21

    Google Scholar 

  • Oray M, Meese H, Foster CS (2016) Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects. Expert Rev Clin Immunol 12:827–837

    CAS  PubMed  Google Scholar 

  • Pérez-Jacoiste Asín MA, Charles P, Rothschild PR, Terrier B, Brézin A, Mouthon L, Guillevin L, Puéchal X (2019) Ocular involvement in granulomatosis with polyangiitis: a single-center cohort study on 63 patients. Autoimmun Rev 18:493–500

    PubMed  Google Scholar 

  • Pleyer U, Bertelmann E, Rieck P, Hartmann C (2002) Outcome of penetrating keratoplasty in rheumatoid arthritis. Ophthalmologica 216(4):249–255

    CAS  PubMed  Google Scholar 

  • Pleyer U, Mackensen F, Winterhalter S, Stübiger (2011) Anti-TNF-α treatment for uveitis. Analysis of the current situation. Ophthalmologe 108(1):13–20

    CAS  PubMed  Google Scholar 

  • Pohlmann D, Pleyer U (2018) Scleritis – Fortschritte in Diagnostik und Therapie. Klin Monatsbl Augenheilkd 235:603–610

    Google Scholar 

  • Pohlmann D, Winterhalter S, Pleyer U (2018) Intravitreal Dexamethasone for the Treatment of CMO Associated with Refractory Sclerouveitis. Ocul Immunol Inflamm 26:160–165. https://doi.org/10.1080/09273948.2016.1196712. Epub 2016 Jul 20. PMID: 27438231

  • Prada J, Noelle B, Baatz H et al (2003) Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations. Br J Ophthalmol 87(5):548–550

    CAS  PubMed  PubMed Central  Google Scholar 

  • Raiji VR, Palestine AG, Parver DL (2009) Scleritis and systemic disease association in a community-based referral practice. Am J Ophthalmol 148(6):946–950

    PubMed  Google Scholar 

  • Restrepo JP, Molina MP (2010) Successful treatment of severe nodular scleritis with adalimumab. Clin Rheumatol 29(5):559–561

    PubMed  Google Scholar 

  • Riley GP, Harrall RL, Watson PG et al (1995) Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye (Lond) 9:703–718

    Google Scholar 

  • Riono WP, Hidayat AA, Rao NA (1999) Scleritis: a clinicopathologic study of 55 cases. Ophthalmology 106(7):1328–1333

    CAS  PubMed  Google Scholar 

  • Rothschild PR, Pagnoux C, Seror R, Brézin AP, Delair E, Guillevin L (2013) Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature. Semin Arthritis Rheum 42:507–514

    PubMed  Google Scholar 

  • Roufas A, Jalaludin B, Gaskin C, McCluskey P (2010) Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis. Br J Ophthalmol 94(6):743–747

    CAS  PubMed  Google Scholar 

  • de la Sainz Maza M, Foster CS, Jabbur NS, Baltatzis S (2002) Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol 120(1):15–19

    Google Scholar 

  • Sen HN, Sangave AA, Goldstein DA, Suhler EB, Cunningham D, Vitale S, Nussenblatt RB (2011) A standardized grading system for scleritis. Ophthalmology 118(4):768–771

    PubMed  Google Scholar 

  • Sharma SM, Damato E, Hinchcliffe AE, Andrews CD, Myint K, Lee R, Dick AD (2019) Long-term efficacy and tolerability of TNFα inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance study. Br J Ophthalmol Mar 12

    Google Scholar 

  • Sohn EH, Wang R, Read R, Roufas A, Moorthy R, Albini T et al (2011) Long-term, multi-center evaluation of subconjunctival injection of triamcinolone for non-necrotizing, non-infectious anterior scleritis. Ophthalmology 118(10):1832–1837

    Google Scholar 

  • Stem MS, Todorich B, Faia LJ (2017) Ocular pharmacology for scleritis: review of treatment and a practical perspective. J Ocul Pharmacol Ther 33:240–246

    CAS  PubMed  Google Scholar 

  • Usui Y, Parikh J, Goto H, Rao NA (2008) Immunopathology of necrotising scleritis. Br J Ophthalmol 92(3):417–419

    PubMed  Google Scholar 

  • Watson PG, Hayreh SS (1976) Scleritis and episcleritis. Br J Ophthalmol 60:163–191

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wei DW, Pagnoux C, Chan CC (2017) Peripheral ulcerative keratitis secondary to chronic hepatitis B infection. Cornea 36:515–517

    PubMed  Google Scholar 

  • Weiss K, Rieger R, Keitzer R, Pleyer U (2007) Successful infliximab treatment of posterior scleritis in a 13-year-old child refractory to other immunosuppressive therapy. Graefes Arch Clin Exp Ophthalmol 245:1735–1737

    CAS  PubMed  Google Scholar 

  • Yin J, Singh RB, Al Karmi R, Yung A, Yu M, Dana R (2019) Outcomes of cyanoacrylate tissue adhesive application in corneal thinning and perforation. Cornea 38:668–673

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Berlin Charité Campus Virchow-Klinikum, Berlin, Deutschland

    Uwe Pleyer

  2. Campus Virchow Klinikum, Klinik für Augenheilkunde, Charité-Universitätsmedizin Berlin, Berlin, Deutschland

    Juliane Schlomberg

Authors
  1. Uwe Pleyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juliane Schlomberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Uwe Pleyer .

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Berlin Charité Campus Virchow-Klinikum, Berlin, Deutschland

    Uwe Pleyer

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pleyer, U., Schlomberg, J. (2021). Episkleritis und Skleritis (engl.: Scleritis; griechisch sklērós = spröde, hart). In: Pleyer, U. (eds) Entzündliche Augenerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-60399-4_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-60399-4_17

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-60398-7

  • Online ISBN: 978-3-662-60399-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation